XZME:XETRA:XETRA-Xtrackers MSCI USA ESG UCITS ETF 2C EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 8.393

Change

-0.13 (-1.47)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.17 (-2.58%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.93 (-1.96%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.49 (-2.11%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.22 (-1.65%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.13 (-2.51%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.29 (-1.27%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.27 (-2.08%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.16 (-0.31%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.21 (-2.04%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.54 (-0.45%)

USD 12.26B

ETFs Containing XZME:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.34% 19% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.34% 19% F 19% F
Trailing 12 Months  
Capital Gain 3.29% 45% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.29% 46% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.79% 80% B- 78% C+
Dividend Return 14.79% 80% B- 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.18% 43% F 53% F
Risk Adjusted Return 104.27% 88% B+ 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.